Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumazenil for Hypoactive Delirium in the ICU
NCT02899156Phase 4Terminated
- Sponsor
- University of California, Davis
- Start
- Mar 2016
- Primary completion
- Apr 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of flumazenil in delirium, sponsored by University of California, Davis. Started Mar 2016; status: terminated.
02
Drugs
flumazenil
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02899156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02899156.